Cardiovascular Department, Ospedale S.Donato
Arezzo, AR, 52100, Italy
NCT Number: NCT02356523
The Purpose of this study is to evaluate the incidence of delirium in patients with acute coronary syndromes admitted to a Intensive Care Unit Patients.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Arezzo, AR, 52100, Italy
The present study is a prospective, two-centre registry aimed at assessing the incidence, prevalence and prognostic significance of delirium in elderly patients with acute coronary syndromes
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administration of Confusion Assessment Method at patent over 65 years at admission and every day until discharge
Time frame: within 24 hours of admission
incidence of delirium in elderly patients with coronary acute syndromes
Time frame: 6 months
any adverse event occurred to patients during hospital stay not due to the illness
Ospedale San Donato
Other
Long-term Prognostic Value of Delirium in Elderly Patients With Acute Coronary Syndrome Admitted to Two Cardiac Intensive Care Units: a Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02548975
Confusion, Delirium
View Trial DetailsNCT06963112
Anxiety, Anxiety Disorders
Guangxi, China
View Trial DetailsNCT07151716
Confusion, Delirium
Beijing, Beijing Municipality, China
View Trial DetailsNCT03317067
Aberrant Motor Behavior in Dementia, Agitation
Clermont-Ferrand, France
View Trial Details